[HTML][HTML] HIF-2α, but not HIF-1α, promotes iron absorption in mice

M Mastrogiannaki, P Matak, B Keith… - The Journal of …, 2009 - Am Soc Clin Investig
M Mastrogiannaki, P Matak, B Keith, MC Simon, S Vaulont, C Peyssonnaux
The Journal of clinical investigation, 2009Am Soc Clin Investig
HIF transcription factors (HIF-1 and HIF-2) are central mediators of cellular adaptation to
hypoxia. Because the resting partial pressure of oxygen is low in the intestinal lumen,
epithelial cells are believed to be mildly hypoxic. Having recently established a link between
HIF and the iron-regulatory hormone hepcidin, we hypothesized that HIFs, stabilized in the
hypoxic intestinal epithelium, may also play critical roles in regulating intestinal iron
absorption. To explore this idea, we first established that the mouse duodenum, the site of …
HIF transcription factors (HIF-1 and HIF-2) are central mediators of cellular adaptation to hypoxia. Because the resting partial pressure of oxygen is low in the intestinal lumen, epithelial cells are believed to be mildly hypoxic. Having recently established a link between HIF and the iron-regulatory hormone hepcidin, we hypothesized that HIFs, stabilized in the hypoxic intestinal epithelium, may also play critical roles in regulating intestinal iron absorption. To explore this idea, we first established that the mouse duodenum, the site of iron absorption in the intestine, is hypoxic and generated conditional knockout mice that lacked either Hif1a or Hif2a specifically in the intestinal epithelium. Using these mice, we found that HIF-1α was not necessary for iron absorption, whereas HIF-2α played a crucial role in maintaining iron balance in the organism by directly regulating the transcription of the gene encoding divalent metal transporter 1 (DMT1), the principal intestinal iron transporter. Specific deletion of Hif2a led to a decrease in serum and liver iron levels and a marked decrease in liver hepcidin expression, indicating the involvement of an induced systemic response to counteract the iron deficiency. This finding may provide a basis for the development of new strategies, specifically in targeting HIF-2α, to improve iron homeostasis in patients with iron disorders.
The Journal of Clinical Investigation